Correction: Cegedim: H1 2020 Earnings

Thursday, 24. September 2020 18:36
 
 

PRESS RELEASE

First-half financial information at June 30, 2020
IFRS – Regulated information – Audited

Cegedim: First half impacted by the health crisis, rebound in activity expected in the second half

  • Revenue decreased by 3.9%
  • Recurring operating income (1) declined by 50.1%
  • Target is for nearly stable FY 2020 revenue and recurring operating income(1)
WEBCAST ON MARCH 19, 2020, AT 6:15 PM PARIS TIME
FR : +33 1 72 72 74 03 USA : +1 646 722 4916 UK : +44(0)207 1943 759 PIN CODE: 13169927#
The webcast is available at: www.cegedim.fr/webcast

Boulogne-Billancourt, France, September 24, 2020, after the market close

Cegedim, an innovative technology and services company, posted consolidated, H1 2020 revenues of €236.2 million, down 3.9% on a reported basis and 2.5% like for like compared with the same period in 2019. Recurring  operating income(1) came to €6.3 million, down 50.1% year on year.

In like-for-like terms, revenue decreased at both operational divisions. The Health insurance, HR and e-services division revenue declined by 2.7% and Healthcare professionals division revenue, by 2.2%.

Recurring operating income(1) declined at the Health insurance, HR and e-services division by €6.6 million but was virtually stable at a the Healthcare professionals division and Corporate and others division.

Income statement summary

  H1 2019 H1 2020 Chg.
  €m % €m % %
Revenues 245.8 100.0% 236.2 100.0% (3.9)%
EBITDA(1) 45.5 18.5% 38.2 16.2% (15.9)%
Depreciation & amortization (32.8) (13.4)% (31.9) (13.5)% (2.7)%
Recurring operating income(1) 12.6 5.1% 6.3 2.7% (50.1)%
Other non-recurring operating income and expenses(1) (16.3) (6.6)% (6.2) (2.6)% (62.1)%
Operating income (3.6) (1.5)% 0.1 0.1% n.m.
Cost of net financial debt (4.5) (1.8)% (4.6) (1.9)% +2.4%
Tax expenses (2.1) (0.8)% (0.2) (0.1)% (89.8)%
Consolidated net profit          
Profit attributable to the owners of the parent (10.2) (4.1)% (4.7) (2.0)% (54.2)%
Recurring EPS (0.4) ( (0.2) ( (49.0)%
EPS (0.7)   (0.3) ( (54.1)%

(1) See the 2020 Interim Financial Report, Chapter 3 “Condensed consolidated interim financial statements”, Section 3.6, Note 2 on Alternative performance indicators and Note 6 “Segment reporting”.

Consolidated revenue decreased by €9.6 million, or 3.9%, to €236.2 million in H1 2020, compared to €245.8 million for H1 2019. Currencies had virtually no impact and, excluding an unfavorable scope impact of 1.4pp, revenues fell 2.5%.  

Recurring operating income(1) decreased by €6.3 million, or 50.1%, to €6.3 million in H1 2020, compared with €12.6 million in H1 2019. The June 2020 figure represented 2.7% of revenue, compared with 5.1% in June 2019.

Depreciation and amortization expenses decreased by €0.9 million, or 2.7%, to €31.9 million in H1 2020, compared with €32.8 million in H1 2019.

EBITDA(1) decreased by €7.2 million, or 15.9%, to €38.2 million in H1 2020, compared with €45.5 million in H1 2019. EBITDA represented 16.2% of consolidated revenue in H1 2020, compared with 18.5% in H1 2019.

Other non-recurring operating income and expenses(1) amounted to a charge of €6.2 million in H1 2020 compared with a charge of €16.3 million in H1 2019. Most of the yoy decrease are attributable to “Provisions for intangible asset obsolescence”. The 2020 figure is largely attributable to a €4.3 million impairment for certain intangible assets of the UK doctor software business stemming from previous acquisitions, and much of the 2019 figure is attributable to the sale of nearly all of the business activities of Pulse Systems Inc, which resulted in a €14.9 million charge.

Cost of net financial debt remained relatively stable at €4.6 million in H1 2020, compared with €4.5 million in H1 2019.  This stability reflects the debt structure and reduced use of the revolving credit facility (RCF).

Tax came to a charge of €0.2 million in H1 2020 compared with a charge of €2.1 million in H1 2019, down €1.9 million or 89.8%. This change was principally the result of a decrease in taxes at the Group level and from a positive adjustment in deferred tax assets.

As a result, consolidated net profit came to a loss of €4.6 million in H1 2020 compared with a loss of €10.2 million in H1 2019. Recurring net profit per share came to a loss of €0.2 in H1 2020 compared to a loss of €0.4 in H1 2019. Earnings per share were a loss of €0.3 in H1 2020 compared with a loss of €0.7 a year earlier.

Analysis of business trends by division

·Key figures by division

    Revenues   Recurring Operating Income(1)
In € million   H1 2019 H1 2020   H1 2019 H1 2020
Health insurance, HR and e-services   162.5 160.3   10.7 4.1
Healthcare professionals   81.6 74.1   2.9 3.0
Corporate and others   1.7 1.7   (1.0) (0.9)
Cegedim   245.8 236.2   12.6 6.3

·Health insurance, HR and e-services

In the first half of 2020, the Health insurance, HR and e-services division reported revenues of €160.3 million, down 1.3% on a reported basis and 2.7% like-for like. Currencies had virtually no impact and the acquisitions of Cosytec and NetEDI made a positive contribution of 1.4pp. Recurring operating income(1) decreased by €6.6 million, or 61.3%, to €4.1 million in H1 2020 compared to €10.7 million in H1 2019. The H1 2020 figure represented 2.6% of revenue, compared with 6.6% in H1 2019.

Business was negatively affected by the pandemic across the board. BPO volumes dipped temporarily. Project-based activities were affected because implementation was delayed until the second half. C-Media (conventional and digital signage solutions for pharmacies) suspended all activity for one month because advertisers postponed their marketing spending.

·Healthcare professionals

In the first half of 2020, the Healthcare professionals division reported revenues of €74.1 million, down 9.1% on a reported basis and 2.2% like-for like. Currency translation had a negative impact of 0.1% and acquisitions and disposals had a negative impact of 6.8%, chiefly due to the sale of nearly all of the business activities of Pulse Systems Inc. in the US in August 2019. Recurring operating income(1) increased by €0.1 million, or 2.7%, to €3.0 million in H1 2020 compared to €2.9 million in H1 2019. The H1 2020 figure represented 4.1% of revenue, compared with 3.6% in H1 2019.

This increase in recurring operating income(1) is chiefly attributable to the sale of nearly all of the business activities of Pulse Systems Inc. in August 2019 (which generated a €2.8 million recurring operating loss in H1 2019), to the virtual stability of the division’s recurring business, and to growth at: RESIP (BCB medication database), RM Ingénierie (allied health professional computerization in France), and the doctor software business in the UK. This performance was partially offset by costs at Maiia (online appointment scheduling and telemedicine), whose strong H1 growth will have a positive impact starting in the second half.


·Corporate and others

In the first half of 2020, the Corporate and others division reported revenues of €1.7 million, stable on a reported basis and like-for like. Currencies and acquisitions had no impact. Recurring operating income(1) was relatively stable at a €0.9 million loss over H1 2020, compared with a €1.0 million loss in H1 2019.

Balance sheet structure

The consolidated total balance sheet amounted to €870.0 million at June 30, 2020, a €61.4 million or 7.6% increase over December 31, 2019. This increase is mainly attributable to the €55.7 million increase in receivables linked to outsourced management contracts in the health insurance sector.

Goodwill amounted to €186.0 million at June 30, 2020, compared with €192.7 million at December 31, 2019. This €6.7 million decrease, or 3.5%, was the result of assigning €4.1 million of goodwill from 2019 acquisitions to other identifiable assets, and of a €2.6 million currency impact. Goodwill represented 21.4% of the total balance sheet at June 30, 2020, compared with 23.8% at December 31, 2019.

Cash and equivalents came to €26.1 million at June 30, 2020, a €2.9 million decrease compared to December 31, 2019. This decrease is chiefly attributable to the €2.6 million drop in prepaid income at the health insurance BPO business.

Equity decreased by €10.3 million, or 5.1%, to €191.0 million at June 30, 2020, compared with €201.2 million at December 31, 2019.

Total net financial liabilities(1) amounted to €176.1 million, down €4.4 million compared with 6 months ago. Total net financial liabilities(1) represented 92.2% of equity at June 30, 2020, compared with 89.7% at December 31, 2019.

Cash flow after cost of net financial debt and taxes increased by €55.6 million to an inflow of €50.7 million at June 30, 2020, compared with an outflow of €4.9 million at December 31, 2019. The improvement in WCR is attributable to a €15 million boost from the postponement of social charges and rent payments as a result of efforts to mitigate the impacts of the Covid-19 crisis, the termination of non-recourse factoring agreements in December 2019 (€14.9 million impact at June 30, 2019), and the fluctuation in advances paid by client at the health Insurance BPO business.

Highlights

Apart from the items cited below, to the best of the company’s knowledge, there were no events or changes during the period that would materially alter the Group’s financial situation.

·Tax
On February 21, 2018, Cegedim SA received official notice that the French tax authorities planned to perform an audit of its financial statements for the period from January 1, 2015, to December 31, 2016. After consultation with its lawyers and based on ample precedent, the Group believes that the adjustment is unwarranted. By appealing the case, we were able to obtain tax relief that brings the maximum possible amount of back taxes owed at June 30, 2020, to €8.5 million (vs. €9 million). Regarding the other points of disagreement, the Group has decided to explore its options for recourse before requesting an appeal. Cegedim still believes that there is not enough risk with respect to past deferred tax assets or to tax loss carryforwards recorded on its balance sheet as of June 30, 2020, (corresponding to €20 million of deferred tax) to jeopardize their valuation.

Significant post-closing transactions and events

No significant events occurred between June 30, 2020, and September 24, 2020, when the Board of Directors authorized the condensed consolidated interim financial statements for issue.

Outlook

The Group has a solid business model, a robust financial situation with a reasonable amount of leverage(1), no debt maturing before October 2024, an undrawn €65 million revolving credit facility, and an unused €11 million overdraft facility on the date this report was published.

First-half revenues fell 2.5% like for like, and recurring operating profit fell 50.1%.

The Group operates predominantly in the healthcare sector and expects business at its two operating divisions to rebound in H2 2020, with a return to organic growth in revenue and recurring operating income.

Consequently, relative to 2019, Cegedim is looking for nearly stable FY 2020 revenue and recurring operating income. These targets may need to be revised if the Covid-19 crisis causes a severe tightening of public health restrictions after the first-half accounts are published.

The Group does not expect any material acquisitions in 2020 and does not provide earnings estimates or forecasts.

Additional information

The Audit Committee met on September 23, 2020. The Board of Directors, chaired by Jean-Claude Labrune, approved the consolidated interim financial statements for 2020 at its meeting on September 24, 2020. The audit of the financial statements has been completed. The audit report has been issued. The 2020 Interim Financial Report will be available in a few days’ time on our website and on Cegedim IR, the Group’s financial communications app.

2020 Financial calendar

  September 25 at 10:00 am

October 28 after the close

December 15 (time t.b.a.)
Analyst meeting (SFAF) in SFAF’s offices

Third-quarter 2020 revenues

Cegedim’s Investor Day
 
  The H1-2020 earnings presentation is available at:


Annex 1: Financial statements as of June 30, 2020

·Assets as June 30, 2020

In thousands of euros 06/30/2020 12/31/2019
Goodwill on acquisition 186,026 192,740
Development costs 46,208 21,960
Other intangible fixed assets 117,730 135,579
Intangible fixed assets 163,938 157,540
Property 544 544
Buildings 2,670 2,960
Other tangible fixed assets 30,638 30,960
Right-of-use assets 68,870 64,537
Fixed assets in progress & Advances and deposits on tangible fixed assets 21 163
Tangible fixed assets 102,744 99,164
Equity investments 1,182 1,214
Loans 15,317 14,017
Other long-term investments 5,545 4,546
Long-term investments – excluding equity shares in equity method companies 22,045 19,777
Equity shares in equity method companies 15,639 15,080
Deferred tax asset 32,207 31,750
Accounts receivable: long-term portion - -
Other receivables: long-term portion - -
Long-term financial instruments 266 387
Prepaid expenses: long-term portion 319 390
Non-current assets 523,184 516,828
Services in progress - -
Goods 4,829 4,434
Advances and deposits received on orders 248 208
Accounts receivables: short-term portion 139,516 143,986
Other receivables: short-term portion 161,432 101,684
Short-term financial instruments 1 1
Cash equivalents 0 0
Cash 26,120 29,059
Prepaid expenses: short-term portion 14,697 12,414
Current assets 346,844 291,785
Total Assets 870,027 808,613

At June 30, 2020, the Group’s cash position was positively impacted by €11 million, compared with a negative impact of €32.2 million at December 31, 2019, because prepaid income in the health insurance BPO activity was classified as “other current receivables” to reflect the special terms of some contracts.


·Liabilities and shareholders’ equity as of June 30, 2020

In thousands of euros 06/30/2020 12/31/2019
Share capital 13,337 13,337
Group reserves 188,159 186,526
Group exchange gains/losses -6,031 -1,480
Group earnings -4,667 2,697
Shareholders’ equity, Group share 190,798 201,080
Minority interests 192 167
Shareholders’ equity 190,990 201,247
Long-term financial liabilities 196,319 195,694
Non-current lease liabilities 56,425 52,413
Long-term financial instruments 397 627
Deferred tax liabilities 8,900 8,009
Retirement commitments 33,958 32,250
Non-current provisions 1,906 1,855
Other non-current liabilities - -
Non-current liabilities 297,905 290,847
Short-term financial liabilities 5,950 13,961
Current lease liabilities 14,186 13,507
Short-term financial instruments 2 2
Accounts payable and related accounts 47,702 50,644
Tax and social liabilities 102,205 91,593
Provisions 4,207 5,513
Other current liabilities 206,881 141,299
Current liabilities 381,132 316,519
Total Liabilities 870,027 808,613


·Income statement as of June 30, 2020

In thousands of euros 06/30/2020 06/30/2019
Revenue 236,199 245,795
Purchased used (12,039) (15,260)
External expenses (51,909) (55,693)
Taxes (5,097) (4,425)
Payroll costs (127,901) (124,640)
Impairment on account receivables and other receivables and on contract assets (2,102) (38)
Allocations to and reversals of provisions (706) (1,332)
Change in inventories of products in progress and finished products - (79)
Other operating income and expenses 146 (282)
Income of equity-accounted affiliates 1,656 1,426
EBITDA(1) 38,247 45,472
Depreciation expenses other than right-of-use assets (24,259) (25,078)
Depreciation expenses of right-of-use assets (7,684) (7,750)
Recurring operating income before special items(1) 6,305 12,643
Depreciation of goodwill - (2,500)
Non-recurring income and expenses(1) (6,167) (13,784)
Other non-recurring operating income and expenses(1) (6,167) (16,284)
Operating income 138 (3,640)
Income from cash and cash equivalents 35 52
Gross cost of financial debt (4,266) (4,387)
Other financial income and expenses (335) (125)
Cost of net financial debt (4,566) (4,460)
Income taxes (516) (1,914)
Deferred taxes 304 (168)
Total taxes (212) (2,082)
Share of profit (loss) for the period of equity method companies 0 (8)
Consolidated profit (loss) for the period (4,640) (10,190)
Consolidated net income (loss) attributable to owners of the parent (4,667) (10,180)
Income from of equity-accounted affiliates 26 10
Average number of shares excluding treasury stock 13,826,606 13,853,244
Current earnings per share (in euros) (0.2) (0.4)
Earnings per share (in euros) (0.3) (0.7)
Dilutive instruments None None
Earning for recurring operation per share (in euros) (0.3) (0.7)

(1) See in the 2020 Interim Financial Report, Chapter 3 “Condensed consolidated interim financial statements”, Section 3.6, Note 2 on Alternative performance indicators and Note 6 “Segment reporting”.


·Consolidated cash flow statement as of June 30, 2020

In thousands of euros 06/30/2020 06/30/2019
Consolidated profit (loss) for the period (4,641) (10,190)
Share of earnings from equity method companies (1,656) (1,417)
Depreciation and provisions 36,425 48,220
Capital gains or losses on disposals (253) (25)
Cash flow after cost of net financial debt and taxes 29,875 36,588
Cost of net financial debt 4,566 4,460
Tax expenses 212 2,082
Operating cash flow before cost of net financial debt and taxes 34,653 43,130
Tax paid (2,140) (473)
Change in working capital requirements for operations: requirement - (47,584)
Change in working capital requirements for operations: surplus 18,138 -
Cash flow generated from operating activities after tax paid and change in working capital requirements (a) 50,651 (4,927)
Acquisitions of intangible assets (27,848) (26,066)
Acquisitions of tangible assets (5,009) (4,880)
Acquisitions of long-term investments (980) 391
Disposals of tangible and intangible assets 332 51
Disposals of long-term investments 27 -
Change in loans made and cash advances (1,309) 555
Impact of changes in consolidation scope(1) - (10,922)
Dividends received 79 97
Net cash flows generated by investment operations (b) (34,708) (40,773)
Dividends paid to shareholders of the parent company - -
Dividends paid to the equity-accounted affiliates -  
Capital increase for cash -  
Loans issued - -
Loans repaid (9,834) (354)
Repayment of lease liabilities (7,521) (7,017)
Interest paid on loans (262) (245)
Other financial income received 75 52
Other financial expenses paid (1,190) (1,766)
Net cash flows generated by financing operations (c) (18,731) (9,330)
Change in cash before impact of change in foreign currency exchange rates
(a+b+c)
(2,788) (55,030)
Impact of changes in foreign currency exchange rates (154) 96
Change in cash (2,943) (54,934)
Opening cash 29,059 81,088
Closing cash 26,116 26,154


BPO (Business Process Outsourcing):  BPO is the contracting of non-core business activities and functions to a third-party provider. Cegedim provides BPO services for human resources, Revenue Cycle Management in the US and management services for insurance companies, provident institutions and mutual insurers.

Business model transformation: Cegedim decided in fall 2015 to switch all of its offerings over to SaaS format, to develop a complete BPO offering, and to materially increase its R&D efforts. This is reflected in the Group’s revamped business model. The change has altered the Group's revenue recognition and negatively affected short-term profitability.

Corporate and others: This division encompasses the activities the Group performs as the parent company of a listed entity, as well as the support it provides to the three operating divisions.

Operating margin: Operating margin is defined as the ratio of Operating Income on revenue.

Recurring operating margin: Recurring operating margin is defined as the ratio of recurring operating income to revenue.

EPS: Earnings Per Share is a specific financial indicator defined by the Group as the net profit (loss) for the period divided by the weighted average of the number of shares in circulation.
  External growth: External growth covers acquisitions during the current fiscal year, as well as those which have had a partial impact on the previous fiscal year, net of sales of entities and/or assets.

Free cash flow: Free cash flow is cash generated, net of the cash part of the following items: (i) changes in working capital requirements, (ii) transactions on equity (changes in capital, dividends paid and received), (iii) capital expenditure net of transfers, (iv) net financial interest paid and (v) taxes paid.

Internal growth: Internal growth covers growth resulting from the development of an existing contract, particularly due to an increase in rates and/or the volumes distributed or processed, new contracts, acquisitions of assets allocated to a contract or a specific project.

Life-for-like data (LFL): At constant scope and exchange rates.

Net cash: Net cash is defined as cash and cash equivalent minus overdraft.

Operating expenses: Operating expenses is defined as purchases used, external expenses and payroll costs.
     

Glossary

Disclaimer: This press release is available in French and in English. In the event of any difference between the two versions, the original French version takes precedence. This press release may contain inside information. It was sent to Cegedim’s authorized distributor on September 24, 2020, no earlier than 5:45 pm Paris time.
The figures cited above include guidance on Cegedim’s future financial performances. This forward-looking information is based on the opinions and assumptions of the Group’s senior management at the time this press release is issued and naturally entails risks and uncertainty. For more information on the risks facing Cegedim, please refer to Chapter 7 “Risk management”, point 7.2, “Risk factors”, and Chapter 3 “Overview of the financial year” point 3.6 “Outlook”, of the 2019 Universal Registration Document filled with the AMF on March 31, 2020 under number D.20-0218.


About Cegedim:

Founded in 1969, Cegedim is an innovative technology and services company in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs almost 5,000 people in more than 10 countries and generated revenue in excess of €500 million in 2019. Cegedim SA is listed in Paris (EURONEXT: CGM).
To learn more, please visit: www.cegedim.com
And follow Cegedim on Twitter: @CegedimGroup, LinkedIn and Facebook.

 



Aude Balleydier
Cegedim
Media Relations
and Communications Manager
Tel.: +33 (0)1 49 09 68 81
aude.balleydier@cegedim.com

Jan Eryk Umiastowski
Cegedim
Chief Investment Officer
and head of Investor Relations
Tel.: +33 (0)1 49 09 33 36
janeryk.umiastowski@cegedim.com

Céline Pardo & Irène Semeraro
suPR
Relations Médias
Tel.:  +33 (0)6 52 08 13 66
        +33 (0)6 80 80 83 97
cegedim@supr-agency.com
 

 

 

Attachment

Primary Logo

Related Links: 
Author:
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.